Dynamic revenues nearly cut in half

Article

Dynamic revenues nearly cut in halfDynamic Healthcare Technologies blamed slow market reaction to new product introductions and continued delays in sales cycles for a disappointing first quarter. Revenues declined during the period by 44%.For

Dynamic revenues nearly cut in half

Dynamic Healthcare Technologies blamed slow market reaction to new product introductions and continued delays in sales cycles for a disappointing first quarter. Revenues declined during the period by 44%.

For the quarter (end-March), revenues were $6 million, compared with $10.7 million reported in the 1997 first quarter. The Maitland, FL-based company had a net loss of $2.9 million, compared with net income of $3 million in the same period last year.

Dynamic is experiencing prolonged sales cycles and contract closings, a trend the company believes is temporary. In addition, the company was hurt by a time lag between implementation of its new technology at initial sites and the ability of those sites to demonstrate the value of the technology, according to the company.

In any event, Dynamic is in the midst of a corporate streamlining and functional reorganization plan, which the company expects will result in a number of benefits such as more cost-effective operations and consistent delivery of products and solutions. The plan, which has a cost-reduction target of 20%, will continue through the second quarter.

In other company news, Dynamic has signed a loan commitment from a commercial bank for a $5 million revolving line of credit and a $200,000 guidance line of credit. The lender's obligation to close on the two lines of credit is conditioned upon conducting a satisfactory pre-closing audit and a company infusion of cash equity of $2.8 million on terms satisfactory to the lender.

Recent Videos
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
Related Content
© 2025 MJH Life Sciences

All rights reserved.